Medicilon and Korea Pharmaceutical Manufacturers Association (KPMA) will co-host a seminar on March 18 in Seoul, South Korea with topic, “Experience Sharing and Exchange on CFDA’s IND Application and Drug Development Collaboration”. Medicilon CEO, Dr. Chunlin Chen, will be the one of the guest speaker to share his experience on CFDA IND filing. If you want to receive the seminar information, please feel free to contact us.